ZUG, Switzerland
,
February 27, 2024
(press release)
–
Coca-Cola HBC Finance B.V
. issued €600 million aggregate principal amount of 3.375% Notes due
27 February 2028
under its €5,000,000,000 Euro Medium Term Note Programme, guaranteed by
Coca-Cola HBC AG
. The Base Prospectus dated
19 December 2023
, supplemented on
15 February 2024
, is essential for understanding the terms. The Notes are not offered for sale in
the United States
and will be offered only in offshore transactions to non-
U.S.
persons under Regulation S.
Original Press Release:
Zug
, Switzerland,Amsterdam,
The Netherlands
,
Feb. 23
--
Coca-Cola HBC AG
issued the following news release:
The following Final Terms are available for viewing:
* Final Terms dated
23 February 2024
in respect of the €600 million aggregate principal amount of 3.375 per cent. Notes due
27 February 2028
;
to be issued by
Coca-Cola HBC Finance B.V
. under its €5,000,000,000 Euro Medium Term Note Programme, and guaranteed by
Coca-Cola HBC AG
.
This announcement must be read in conjunction with the Base Prospectus dated
19 December 2023
, as supplemented on
15 February 2024
(the "Base Prospectus") which constitutes a base prospectus for the purposes of Regulation (EU) 2017/1129 as it forms part of domestic law in the
United Kingdom
by virtue of the
European Union
(Withdrawal) Act 2018, as amended.
To view the Final Terms and the Base Prospectus, please paste the following URL into the address bar of your browser:
https://www.coca-colahellenic.com/en/investor-relations/debt-investors
The Final Terms have also been submitted to the National Storage Mechanism and will shortly be available for inspection at:
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
[Category: Beverage & Tobacco, Soft Drinks, Regulatory and Legal]
Source:
Coca-Cola HBC AG
* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistribute or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.